Live Breaking News & Updates on News ratings for roivant sciences daily

Stay informed with the latest breaking news from News ratings for roivant sciences daily on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in News ratings for roivant sciences daily and stay connected to the pulse of your community

Roivant Sciences (NASDAQ:ROIV) Rating Reiterated by HC Wainwright

Roivant Sciences (NASDAQ:ROIV) Rating Reiterated by HC Wainwright
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Piper-sandler , Eric-venker , Roivant-sciences , Analyst-recommendations-for-roivant-sciences , Roivant-sciences-ltd , Institutional-trading-of-roivant-sciences , Insider-activity-at-roivant-sciences , Goldman-sachs-group , Securities-exchange-commission , Norges-bank

HC Wainwright Reaffirms "Buy" Rating for Roivant Sciences (NASDAQ:ROIV)

HC Wainwright Reaffirms "Buy" Rating for Roivant Sciences (NASDAQ:ROIV)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Eric-venker , Corton-capital-inc , News-ratings-for-roivant-sciences-daily , Morgan-stanley , Citigroup-inc , Roivant-sciences-stock-performance , Securities-exchange-commission , Deutsche-bank-aktiengesellschaft , Roivant-sciences-ltd , Goldman-sachs-group

HC Wainwright Reaffirms "Buy" Rating for Roivant Sciences (NASDAQ:ROIV)

Roivant Sciences (NASDAQ:ROIV – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a report issued on Monday, Benzinga reports. They presently have a $18.00 target price on the stock. HC Wainwright’s price target indicates a potential upside of 64.53% from the company’s previous close. Other research analysts […]

United-states , Alaska , Louisiana , America , Eric-venker , Analyst-recommendations-for-roivant-sciences , Nasdaq , Roivant-sciences , Roivant-sciences-ltd , Alaska-department-of-revenue , News-ratings-for-roivant-sciences-daily , Allspring-global-investments-holdings

Roivant Sciences (NASDAQ:ROIV) PT Raised to $15.00

Roivant Sciences (NASDAQ:ROIV – Free Report) had its price objective increased by Deutsche Bank Aktiengesellschaft from $14.00 to $15.00 in a report released on Wednesday, Benzinga reports. They currently have a buy rating on the stock. ROIV has been the subject of several other reports. Piper Sandler started coverage on Roivant Sciences in a research […]

United-states , America , Piper-sandler , Eric-venker , Deutsche-bank-aktiengesellschaft , Deerfield-management-companylp-series , Morgan-stanley , Insider-activity-at-roivant-sciences , Analyst-recommendations-for-roivant-sciences , Roivant-sciences-stock , Citigroup-inc , Roivant-sciences-ltd

HC Wainwright Boosts Roivant Sciences (NASDAQ:ROIV) Price Target to $18.00

Roivant Sciences (NASDAQ:ROIV – Free Report) had its price target upped by HC Wainwright from $17.00 to $18.00 in a research note released on Wednesday morning, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Roivant Sciences’ Q1 2025 earnings at ($0.25) EPS, Q2 2025 earnings […]

United-states , Canada , America , Eric-venker , Piper-sandler , Wolfe-research , Roivant-sciences , Citigroup-inc , Royal-bank , Investment-advisers , Deutsche-bank-aktiengesellschaft , Analyst-recommendations-for-roivant-sciences

Roivant Sciences (NASDAQ:ROIV) Shares Gap Up to $10.08

Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) gapped up prior to trading on Wednesday . The stock had previously closed at $10.08, but opened at $10.72. Roivant Sciences shares last traded at $10.75, with a volume of 4,818,374 shares changing hands. Analysts Set New Price Targets A number of equities research analysts have recently […]

United-states , Canada , America , Piper-sandler , Vivek-ramaswamy , Eric-venker , Roivant-sciences-ltd , Deutsche-bank-aktiengesellschaft , Roivant-sciences-stock-down , Dagco-inc , Royal-bank , Securities-exchange-commission

Truist Financial Reaffirms "Buy" Rating for Roivant Sciences (NASDAQ:ROIV)

Truist Financial reiterated their buy rating on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a research report released on Monday, Benzinga reports. Truist Financial currently has a $23.00 price objective on the stock. A number of other research analysts have also recently issued reports on ROIV. TheStreet raised shares of Roivant Sciences from […]

United-states , America , American , Vivek-ramaswamy , Eric-venker , Nasdaq , Blackrock-inc , Securities-exchange-commission , Citigroup-inc , Roivant-sciences-stock-performance , News-ratings-for-roivant-sciences-daily , York-mellon-corp

Roivant Sciences Ltd. (NASDAQ:ROIV) Stock Holdings Lifted by Deerfield Management Company L.P. Series C

Deerfield Management Company L.P. Series C raised its position in Roivant Sciences Ltd. (NASDAQ:ROIV – Free Report) by 18.4% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,604,487 shares of the company’s stock after acquiring an additional 249,513 shares during […]

Piper-sandler , Eric-venker , Vivek-ramaswamy , Roivant-sciences-ltd , Deutsche-bank-aktiengesellschaft , Securities-exchange-commission , Blackrock-inc , Quarter-for-roivant-sciences , Roivant-sciences-stock-performance , Nasdaq , Roivant-sciences , Deerfield-management-companylp-series

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives $16.56 Consensus PT from Brokerages

Roivant Sciences Ltd. (NASDAQ:ROIV) Receives $16.56 Consensus PT from Brokerages
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada , United-states , America , Eric-venker , Piper-sandler , Vivek-ramaswamy , Analyst-recommendations-for-roivant-sciences , Hedge-funds-weigh-in-on-roivant-sciences , Headlands-technologies , News-ratings-for-roivant-sciences-daily , Roivant-sciences-ltd , Investment-advisers

Wolfe Research Begins Coverage on Roivant Sciences (NASDAQ:ROIV)

Wolfe Research started coverage on shares of Roivant Sciences (NASDAQ:ROIV – Free Report) in a research note published on Thursday, Marketbeat reports. The brokerage issued an outperform rating and a $17.00 price target on the stock. A number of other equities analysts have also recently commented on ROIV. Deutsche Bank Aktiengesellschaft started coverage on shares […]

United-states , America , Piper-sandler , Vivek-ramaswamy , Eric-venker , Roivant-sciences , Jpmorgan-chase-co , Deutsche-bank-aktiengesellschaft , News-ratings-for-roivant-sciences-daily , Roivant-sciences-ltd , Blackrock-inc , Wolfe-research